Affinity Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Affinity Wealth Management's LLY Position: Q3 2026 in Review
Affinity Wealth Management reduced its Eli Lilly (LLY) stake by 4.9% in Q3 2026, selling an estimated $789K and leaving 12,998 shares worth $15M. The position accounts for 2.03% of the portfolio, ranked #25.
Affinity Wealth Management first reported a position in LLY in Q1 2019 and has held it in 21 quarters since. The position peaked at $16.4M in Q2 2026. 4,568 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Affinity Wealth Management held 12,998 shares of Eli Lilly worth $15M as of Q3 2026.
- Affinity Wealth Management sold 669 Eli Lilly shares in Q3 2026, an estimated $789K.
- Eli Lilly made up 2.03% of Affinity Wealth Management's portfolio in Q3 2026, its #25 holding.
- Affinity Wealth Management first reported a position in Eli Lilly in Q1 2019 and has held it in 21 quarters since.
- Affinity Wealth Management's Eli Lilly position peaked at $16.4M in Q2 2026.
- 4,568 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Affinity Wealth Management's 13F filing for Q3 2026, filed 12 Nov 2026.